Get the Stockscreener App
3.88
2.37%
0.09
After Hours:
3.88
Maravai Lifesciences Holdings Inc stock is traded at $3.88, with a volume of 1.86M.
It is up +2.37% in the last 24 hours and up +4.86% over the past month.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
See More
Previous Close:
$3.79
Open:
$3.82
24h Volume:
1.86M
Relative Volume:
1.25
Market Cap:
$562.69M
Revenue:
$288.95M
Net Income/Loss:
$-119.03M
P/E Ratio:
-4.3087
EPS:
-0.9005
Net Cash Flow:
$60.67M
1W Performance:
+18.65%
1M Performance:
+4.86%
6M Performance:
+45.32%
1Y Performance:
-34.79%
1-Day Range:
$3.7816
$4.015
1-Week Range:
$3.19
$4.015
52-Week Range:
$1.665
$6.21
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Name
Maravai Lifesciences Holdings Inc
Sector
Industry
Phone
(858) 546-0004
Address
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Compare MRVI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
3.88 | 549.64M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Neutral |
| Dec-05-24 | Downgrade | Goldman | Neutral → Sell |
| Nov-14-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-08-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-13-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-10-24 | Initiated | Craig Hallum | Buy |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-08-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-23-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| May-09-23 | Downgrade | Goldman | Buy → Neutral |
| Jan-05-23 | Downgrade | UBS | Buy → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Nov-03-22 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Dec-16-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-15-20 | Initiated | BofA Securities | Buy |
| Dec-15-20 | Initiated | Credit Suisse | Outperform |
| Dec-15-20 | Initiated | Goldman | Buy |
| Dec-15-20 | Initiated | Jefferies | Buy |
| Dec-15-20 | Initiated | Robert W. Baird | Outperform |
| Dec-15-20 | Initiated | Stifel | Buy |
| Dec-15-20 | Initiated | William Blair | Outperform |
| Dec-14-20 | Initiated | UBS | Buy |
View All
Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News
A US$75m Market Cap Boost Pleasing ToMaravai LifeSciences Holdings Insiders - simplywall.st
Maravai LifeSciences (NASDAQ:MRVI) Trading Up 11.3%Time to Buy? - MarketBeat
Ideas Watch: Is Maravai LifeSciences Holdings Inc. stock resilient to inflationMarket Volume Summary & Weekly Stock Performance Updates - moha.gov.vn
Maravai LifeSciences Holdings Inc Stock Analysis and ForecastRSI Overbought/Oversold & Free Superior Trading Gains - earlytimes.in
Critical Analysis: Maravai LifeSciences (NASDAQ:MRVI) versus TerrAscend (OTCMKTS:TSNDF) - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Investors Buy Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Shares Down 4.7%What's Next? - MarketBeat
Can Maravai LifeSciences Holdings Inc. (MAR) stock survive global slowdownEarnings Performance Report & Capital Efficient Trade Techniques - Улправда
Does Maravai LifeSciences Holdings Inc. stock trade at a discount to peersTrade Entry Report & AI Optimized Trade Strategies - Улправда
Shorts Report: How Maravai LifeSciences Holdings Inc. (MAR) stock gains from tech spendingJuly 2025 Chart Watch & Expert Approved Trade Ideas - Улправда
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
2025-12-18 | Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation | NDAQ:MRVI | Press Release - Stockhouse
Can Maravai LifeSciences Holdings Inc. stock attract ESG capital inflowsOil Prices & Free Verified High Yield Trade Plans - Улправда
How Maravai LifeSciences Holdings Inc. (MAR) stock gains from tech spendingDip Buying & High Conviction Trade Alerts - Улправда
Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) 29% Jump Shows Its Popularity With Investors - 富途牛牛
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect - ACCESS Newswire
Why Analysts See Maravai’s Story Shifting After Target Cut And Washed Out Share Price Range - Yahoo Finance
Wells Fargo maintains Maravai LifeSciences Holdings (MRVI) overweight recommendation - MSN
MRVI: Wells Fargo Maintains Rating and Raises Price Target | MRV - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2025 in Maravai LifeSciences LawsuitMRVI - ACCESS Newswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionMRVI - 28/22 News
Maravai LifeSciences Holdings, Inc. $MRVI Stock Holdings Boosted by Immersion Corp - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Up Following Insider Buying Activity - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Director Purchases $190,446.40 in Stock - MarketBeat
Maravai Lifesciences (MRVI) Director Acquires 100K Shares - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2025-12-09 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation | NDAQ:MRVI | Press Release - Stockhouse
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Maravai LifeSciences delivers 60% return after March fair value alert By Investing.com - Investing.com Canada
Maravai LifeSciences delivers 60% return after March fair value alert - Investing.com
Harspring Capital Management LLC Acquires New Shares in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Geode Capital Management LLC Has $7.19 Million Stock Position in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Connect - ACCESS Newswire
Will Maravai LifeSciences Holdings Inc. (MAR) stock justify high valuationPortfolio Profit Report & Precise Swing Trade Alerts - Newser
Will Maravai LifeSciences Holdings Inc. (MAR) stock sustain dividend payouts2025 Investor Takeaways & Weekly Consistent Profit Watchlists - Newser
Maravai LifeSciences Reports Q3 2025 Financial Results - MSN
A new trading data show Maravai LifeSciences Holdings Inc (MRVI) is showing positive returns. - Setenews
Maravai LifeSciences (MRVI) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Maravai LifeSciences (NASDAQ:MRVI) Stock Price Down 6.5%Here's What Happened - MarketBeat
Can Maravai LifeSciences Holdings Inc. (MAR) stock test all time highs2025 Investor Takeaways & Daily Stock Trend Watchlist - Newser
Why Analysts See Opportunity and Risk as Maravai’s Story Evolves After Management Shakeup - Yahoo Finance
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of “Hold” by Analysts - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Is Maravai LifeSciences Holdings Inc a good long term investmentTrendline Breakouts & Low Risk Investment Tips - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation - ACCESS Newswire
Tejara Capital Ltd Buys 1,398,900 Shares of Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Maravai Lifesciences Holdings Inc Stock (MRVI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):